Literature DB >> 27754892

In-hospital mortality after hip fracture by treatment setting.

Katie J Sheehan1, Boris Sobolev2, Pierre Guy2, Lisa Kuramoto2, Suzanne N Morin2, Jason M Sutherland2, Lauren Beaupre2, Donald Griesdale2, Michael Dunbar2, Eric Bohm2, Edward Harvey2.   

Abstract

BACKGROUND: Where patients with hip fracture undergo treatment may influence their outcome. We compared the risk of in-hospital death after hip fracture by treatment setting in Canada.
METHODS: We examined all discharge abstracts from the Canadian Institute for Health Information with diagnosis codes for hip fracture involving patients 65 years and older who were admitted to hospital with a nonpathological first hip fracture between Jan. 1, 2004, and Dec. 31, 2012, in Canada (excluding Quebec). We compared the risk of in-hospital death, overall and after surgery, between teaching hospitals and community hospitals of various bed capacities, accounting for variation in length of stay.
RESULTS: Compared with the number of deaths per 1000 admissions at teaching hospitals, there were an additional 3 (95% confidence interval [CI] 1-6), 14 (95% CI 10-18) and 43 (95% CI 35-51) deaths per 1000 admissions at large, medium and small community hospitals, respectively. For the risk of in-hospital death overall, the adjusted odds ratios (ORs) were 1.05 (95% CI 0.99-1.11), 1.16 (95% CI 1.09-1.24) and 1.44 (95% CI 1.31-1.57) at large, medium and small community hospitals, respectively, compared with teaching hospitals. For the risk of postsurgical death in hospital, the adjusted ORs were 1.06 (95% CI 1.00-1.13), 1.13 (95% CI 1.04-1.23) and 1.18 (95% CI 0.87-1.60) at large, medium and small community hospitals, respectively.
INTERPRETATION: Compared with teaching hospitals, the risk of in-hospital death among patients with hip fracture was higher at medium and small community hospitals, and the risk of in-hospital death after surgery was higher at medium community hospitals. No differences were found between teaching and large community hospitals. Future research should examine the role of volume, demand and bed occupancy for observed differences.
© 2016 Canadian Medical Association or its licensors.

Entities:  

Mesh:

Year:  2016        PMID: 27754892      PMCID: PMC5135491          DOI: 10.1503/cmaj.160522

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  35 in total

1.  The association between hospital type and mortality and length of stay: a study of 16.9 million hospitalized Medicare beneficiaries.

Authors:  Z Yuan; G S Cooper; D Einstadter; R D Cebul; A A Rimm
Journal:  Med Care       Date:  2000-02       Impact factor: 2.983

2.  Aggressive treatment style and surgical outcomes.

Authors:  Jeffrey H Silber; Robert Kaestner; Orit Even-Shoshan; Yanli Wang; Laura J Bressler
Journal:  Health Serv Res       Date:  2010-09-28       Impact factor: 3.402

3.  Ninety-day mortality after intertrochanteric hip fracture: does provider volume matter?

Authors:  Mary L Forte; Beth A Virnig; Marc F Swiontkowski; Mohit Bhandari; Roger Feldman; Lynn E Eberly; Robert L Kane
Journal:  J Bone Joint Surg Am       Date:  2010-04       Impact factor: 5.284

4.  Changes in hip fracture incidence, mortality and length of stay over the last decade in an Australian major trauma centre.

Authors:  Nicole Williams; Ben M Hardy; Seth Tarrant; Natalie Enninghorst; John Attia; Christopher Oldmeadow; Zsolt J Balogh
Journal:  Arch Osteoporos       Date:  2013-09-19       Impact factor: 2.617

5.  The effect of hospital type and surgical delay on mortality after surgery for hip fracture.

Authors:  I Weller; E K Wai; S Jaglal; H J Kreder
Journal:  J Bone Joint Surg Br       Date:  2005-03

6.  Different reimbursement influences surviving of hip fracture in elderly patients.

Authors:  Kobi Peleg; Bella Savitsky; Berlovitz Yitzhak; Israeli Avi
Journal:  Injury       Date:  2010-04-24       Impact factor: 2.586

7.  Cytokines and C-reactive protein production in hip-fracture-operated elderly patients.

Authors:  Yichayaou Beloosesky; David Hendel; Avraham Weiss; Avital Hershkovitz; Joseph Grinblat; Anatoly Pirotsky; Vivian Barak
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2007-04       Impact factor: 6.053

8.  Patterns of surgical care and complications in elderly adults.

Authors:  Stacie Deiner; Benjamin Westlake; Richard P Dutton
Journal:  J Am Geriatr Soc       Date:  2014-04-14       Impact factor: 5.562

9.  Charlson comorbidity indices and in-hospital deaths in patients with hip fractures.

Authors:  Valentin Neuhaus; John King; Michiel G Hageman; David C Ring
Journal:  Clin Orthop Relat Res       Date:  2012-11-21       Impact factor: 4.176

10.  Is bigger always better? A nationwide study of hip fracture unit volume, 30-day mortality, quality of in-hospital care, and length of hospital stay.

Authors:  Pia K Kristensen; Theis M Thillemann; Søren P Johnsen
Journal:  Med Care       Date:  2014-12       Impact factor: 2.983

View more
  14 in total

1.  Discharge destination following hip fracture in Canada among previously community-dwelling older adults, 2004-2012: database study.

Authors:  L Beaupre; B Sobolev; P Guy; J D Kim; L Kuramoto; K J Sheehan; J M Sutherland; E Harvey; S N Morin
Journal:  Osteoporos Int       Date:  2019-04-01       Impact factor: 4.507

2.  Association Between Wait Time and 30-Day Mortality in Adults Undergoing Hip Fracture Surgery.

Authors:  Daniel Pincus; Bheeshma Ravi; David Wasserstein; Anjie Huang; J Michael Paterson; Avery B Nathens; Hans J Kreder; Richard J Jenkinson; Walter P Wodchis
Journal:  JAMA       Date:  2017-11-28       Impact factor: 56.272

3.  After hours surgery and mortality: the potential role of acute care surgery models as a factor accounting for results.

Authors:  David R Lardner; Carmen A Brauer; A Rob Harrop; Ali MacRobie
Journal:  CMAJ       Date:  2017-02-06       Impact factor: 8.262

4.  Response to "After hours surgery and mortality: the potential role of acute care surgery models as a factor accounting for results".

Authors:  Katie J Sheehan; Boris Sobolev; Pierre Guy
Journal:  CMAJ       Date:  2017-02-06       Impact factor: 8.262

5.  Mortality effects of timing alternatives for hip fracture surgery.

Authors:  Boris Sobolev; Pierre Guy; Katie Jane Sheehan; Lisa Kuramoto; Jason M Sutherland; Adrian R Levy; James A Blair; Eric Bohm; Jason D Kim; Edward J Harvey; Suzanne N Morin; Lauren Beaupre; Michael Dunbar; Susan Jaglal; James Waddell
Journal:  CMAJ       Date:  2018-08-07       Impact factor: 8.262

6.  Are Case Volume and Facility Complexity Level Associated With Postoperative Complications After Hip Fracture Surgery in the Veterans Affairs Healthcare System?

Authors:  Jimmy K Wong; T Edward Kim; Seshadri C Mudumbai; Stavros G Memtsoudis; Nicholas J Giori; Steven K Howard; Roberta K Oka; Robert King; Edward R Mariano
Journal:  Clin Orthop Relat Res       Date:  2019-01       Impact factor: 4.176

7.  Reporting and evaluating wait times for urgent hip fracture surgery in Ontario, Canada.

Authors:  Daniel Pincus; David Wasserstein; Bheeshma Ravi; James P Byrne; Anjie Huang; J Michael Paterson; Avery B Nathens; Hans J Kreder; Richard J Jenkinson; Walter P Wodchis
Journal:  CMAJ       Date:  2018-06-11       Impact factor: 8.262

Review 8.  Patient and system factors of time to surgery after hip fracture: a scoping review.

Authors:  Katie J Sheehan; Boris Sobolev; Yuri F Villán Villán; Pierre Guy
Journal:  BMJ Open       Date:  2017-08-21       Impact factor: 2.692

9.  In-Hospital Postoperative Pneumonia Following Geriatric Intertrochanteric Fracture Surgery: Incidence and Risk Factors.

Authors:  Kuo Zhao; Junzhe Zhang; Junyong Li; Jialiang Guo; Hongyu Meng; Yanbin Zhu; Yingze Zhang; Zhiyong Hou
Journal:  Clin Interv Aging       Date:  2020-09-08       Impact factor: 4.458

10.  Determinants of mortality after hip fracture surgery in Sweden: a registry-based retrospective cohort study.

Authors:  Rasmus Åhman; Pontus Forsberg Siverhall; Johan Snygg; Mats Fredrikson; Gunnar Enlund; Karin Björnström; Michelle S Chew
Journal:  Sci Rep       Date:  2018-10-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.